SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001185185-12-002354
Filing Date
2012-11-01
Accepted
2012-11-01 16:46:31
Documents
7
Period of Report
2012-07-31

Document Format Files

Seq Description Document Type Size
1 lightlake10ka073112.htm 10-K/A 46266
  Complete submission text file 0001185185-12-002354.txt   3576635

Data Files

Seq Description Document Type Size
2 lltp-20120731.xml EX-101.INS 568084
3 lltp-20120731.xsd EX-101.SCH 54782
4 lltp-20120731_cal.xml EX-101.CAL 25864
5 lltp-20120731_def.xml EX-101.DEF 219933
6 lltp-20120731_lab.xml EX-101.LAB 331965
7 lltp-20120731_pre.xml EX-101.PRE 227096
Mailing Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP
Business Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP 44 (0) 203 617 8739
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-K/A | Act: 34 | File No.: 333-139915 | Film No.: 121174117
SIC: 1000 Metal Mining